Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient

Mult Scler Relat Disord. 2022 Apr:60:103704. doi: 10.1016/j.msard.2022.103704. Epub 2022 Feb 20.

Abstract

Background: The Symbol Digit Modalities Test (SDMT) is a common screen of cognitive function for people with Multiple Sclerosis (pwMS) but growing acknowledgement that people with cognitive impairment are a heterogeneous population suggests that a single screen may provide limited information.

Objective: To assess the adequacy of the SDMT in capturing impairment across specific cognitive domains as measured by a multi-domain cognitive assessment battery (CAB, NeuroTrax).

Methods: 113 pwMS were assessed with SDMT and the CAB. Cognitive impairment in each CAB domain was defined as ≥1.5 SD below the normalized mean. Logistic regression models were fit for each CAB domain with domain-specific cognitive impairment as the outcome and SDMT as the predictor, and a classifier created by selecting cutpoints using the Youden Index. Model performance was assessed by predicting domain-specific cognitive impairment in an independent data set consisting of 81 pwMS.

Results: SDMT was a significant predictor of cognitive impairment in all outcomes considered (Odds Ratio: 0.885-0.950), but prediction metrics such as area under the receiver operating curve (AUC) were modest (0.623-0.778), and the alignment between observed/predicted impairment was less than optimal.

Conclusion: The SDMT is not sufficient to differentiate between impaired and non-impaired pwMS across several cognitive domains.

Keywords: Cognitive function; Cognitive impairment; Computerized cognitive assessment; Multiple sclerosis; Screening; Symbol digit modalities test.

MeSH terms

  • Cognition
  • Cognition Disorders*
  • Cognitive Dysfunction* / diagnosis
  • Cognitive Dysfunction* / etiology
  • Humans
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / diagnosis
  • Multiple Sclerosis* / psychology
  • Neuropsychological Tests